Abstract |
Imidazoline compounds have been considered for the treatment of type 2 diabetes. We have now investigated the effects of imidazolines on interleukin (IL)-1beta-induced beta-cell apoptosis and the signal transduction pathways involved. Inhibition of Ca2+ influx into beta-cells by D-600, a blocker of voltage-gated L-type Ca2+ channels, suppressed IL-1beta-induced apoptosis. Our data show that calcineurin, Ca2+/ calmodulin-dependent serine/ threonine protein phosphatase 2B, is responsible for the effect of Ca2+ on beta-cell apoptosis. We also demonstrate that IL-1beta-mediated apoptosis correlates with expression of inducible nitric oxide synthase (iNOS) and the increase in intracellular production of nitric oxide. An inhibitor of cGMP-dependent protein kinase (PKG), KT5823, suppressed IL-1beta-induced apoptosis, suggesting the involvement of a PKG-dependent pathway in the apoptotic process. One of the major findings in this study is that imidazoline compounds RX871024 and efaroxan, suggested as prototypes of a new generation of drugs against type 2 diabetes, can protect against IL-1beta-induced apoptosis in pancreatic beta-cells, possibly by their inhibition of the expression of iNOS, a key element in the IL-1beta-induced apoptotic pathway in pancreatic beta-cells. These data suggest that imidazoline compounds should be explored as a potential therapeutic agent for the treatment of both type 1 and type 2 diabetes.
|
Authors | S V Zaitsev, I B Appelskog, I L Kapelioukh, S N Yang, M Köhler, S Efendic, P O Berggren |
Journal | Diabetes
(Diabetes)
Vol. 50 Suppl 1
Pg. S70-6
(Feb 2001)
ISSN: 0012-1797 [Print] United States |
PMID | 11272206
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 2-(2-imidazolin-2-yl)-1-phenyl-1H-indole
- Benzofurans
- Calcineurin Inhibitors
- Calcium Channel Blockers
- Calcium Channels
- Enzyme Inhibitors
- Imidazoles
- Indoles
- Interleukin-1
- Nitriles
- Pyrethrins
- decamethrin
- Gallopamil
- Nitric Oxide Synthase
- Nitric Oxide Synthase Type II
- Nos2 protein, mouse
- Calcineurin
- efaroxan
- NG-Nitroarginine Methyl Ester
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Benzofurans
(pharmacology)
- Calcineurin
(metabolism)
- Calcineurin Inhibitors
- Calcium Channel Blockers
(pharmacology)
- Calcium Channels
(physiology)
- Cells, Cultured
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(pharmacology)
- Gallopamil
(pharmacology)
- Imidazoles
(pharmacology)
- Indoles
(pharmacology)
- Interleukin-1
(pharmacology)
- Islets of Langerhans
(cytology, drug effects, physiology)
- Membrane Potentials
(drug effects)
- Mice
- Mice, Obese
- Models, Biological
- NG-Nitroarginine Methyl Ester
(pharmacology)
- Nitric Oxide Synthase
(antagonists & inhibitors, metabolism)
- Nitric Oxide Synthase Type II
- Nitriles
- Patch-Clamp Techniques
- Pyrethrins
(pharmacology)
|